Allstocks.com's Bulletin Board Post New Topic  Post A Reply
my profile login | register | search | faq | forum home

  next oldest topic   next newest topic
» Allstocks.com's Bulletin Board » .11 and Up! » ACTC (Page 1)

 - UBBFriend: Email this page to someone!   This topic comprises 3 pages: 1  2  3   
Author Topic: ACTC
jilly123
Member


Rate Member
Icon 1 posted      Profile for jilly123     Send New Private Message       Edit/Delete Post   Reply With Quote 
NEWS IT OUT

--------------------
www.infopop.com

Posts: 47 | From: germany | Registered: Aug 2006  |  IP: Logged | Report this post to a Moderator
Jo4321
Member


Icon 1 posted      Profile for Jo4321     Send New Private Message       Edit/Delete Post   Reply With Quote 
YEP!

Go here

http://www.allstocks.com/stockmessageboard/ubb/ultimatebb.php/ubb/get_topic/f/2/ t/012759/p/27.html

--------------------
"Great Day for Up!"....Dr. Seuss

Posts: 3387 | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
Related Quotes
Sym. Price Chg.
ACTC Trade
News 0.825 0.035
WiCell Research Institute and Advanced Cell Technology Offer to Distribute New Stem Cell Lines to U.S. Researchers; Agreement Subject to U.S. Federal Government Recognition and Funding of Cell Lines

September 12, 2006 10:48:07 (ET)


MADISON, Wis. and ALAMEDA, Ca., Sep 12, 2006 (BUSINESS WIRE) -- The WiCell Research Institute (WiCell) and Advanced Cell Technology (ACTC, Trade) announced today an agreement, in principle, to collaborate to jointly distribute to U.S. scientists a range of new cell lines. These stem cell lines would be produced using a recently announced technique in the peer-reviewed journal Nature, provided that the United States federal government recognizes these new lines and funds research utilizing them. Under their collaboration, agreed in principle between the parties, Advanced Cell Technology and WiCell hope to make the new stem cell lines readily available to U.S. scientists for medical research.

In its role as the National Stem Cell Bank, WiCell has taken a leadership role in providing cells to academic researchers by providing a free license and training to scientists interested in pursuing this new technology. More than 350 academic research groups are working with cells from WiCell. Under the agreement in principle, WiCell, a subsidiary of the Wisconsin Alumni Research Foundation (WARF), would distribute stem cell lines derived from Advanced Cell Technology's proprietary method, if approved by the President and the National Institutes of Health.

"Provided that the federal government is willing to fund future human embryonic stem cell research where it can be demonstrated that the embryo was not harmed, we will do our part in scaling up many new lines under Good Manufacturing Processes (GMP) guidelines and making such lines available," stated William M. Caldwell, IV., Chief Executive Officer of Advanced Cell Technology. "We are well aware of the impact that delays in advancing new therapies can have on people in need of therapy and provided that the federal government advances legislation in an expeditious manner, we will make the derivation of new lines a company priority."

"Advanced Cell Technology's development is very encouraging," stated Elizabeth Donley, Executive Director of WiCell. "We are hopeful that future human embryonic stem cells created by this new process can be approved for federal funding. Increasing the number of federally funded stem cell lines is essential for speeding the development of this important technology to treat many of human kind's most serious diseases and injuries. WiCell has agreements to distribute 13 of the 21 lines currently available on the National Institutes of Health Registry. We will continue our effort to provide all lines that are eligible for federal funding."

About the WiCell Research Institute

The WiCell Research Institute is dedicated to expanding the frontiers of science and medicine by unlocking the potential of stem cells. As a subsidiary of the Wisconsin Alumni Research Foundation and a supporting organization of the University of Wisconsin-Madison, WiCell conducts research, supports research at UW-Madison, hosts the National Stem Cell Bank, provides training for scientists, and offers educational outreach programs for K-12 students and the community.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

SOURCE: Advanced Cell Technology, Inc.


For Advanced Cell Technology:
FD, Healthcare & Life Sciences
Robert Stanislaro, 212-850-5657
or
For Wisconsin Alumni Research Foundation:
Andy Cohn, 608-263-2821
Copyright Business Wire 2006

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
Related Quotes
Sym. Price Chg.
ACTC Trade
News 0.855 0.105
Advanced Cell Technology Reports Visual Function Rescue in Animals Utilizing Human Embryonic Stem Cell-Derived Retinal Cells; Transplanted Cells Shown Capable of Rescuing Photoreceptor Cells in RCS Rats with Retinal Disease

September 21, 2006 07:00:34 (ET)


WORCESTER, Mass., Sep 21, 2006 (BUSINESS WIRE) -- Advanced Cell Technology, Inc. (OTCBB: ACTC.OB) today announced that company scientists and their collaborators rescued visual function in rats through implantation of retinal pigment epithelial cells (RPE) derived from human embryonic stem (hES) cells. The study results were reported in a paper entitled "Human Embryonic Stem Cell-Derived Cells Rescue Visual Function in Dystrophic RCS Rats" published online today ahead of print in the Fall 2006 issue of the journal Cloning and Stem Cells.

In a series of several experiments, researchers generated RPE cells from 18 different hES cell lines. Cells derived from one of the NIH-approved cell lines were injected into RCS rats in an attempt to compensate for the photoreceptor cell loss caused by a genetic trait carried by such RCS rats. These animals lose their photoreceptor cells over several months following birth and are used to study conditions under which this loss, similar to that occurring in macular degeneration, can be prevented or treated.

In the study published in Cloning and Stem Cells, rats were injected with hES- derived RPE cells into the subretinal space of the eye at 21 days after their birth, an age at which photoreceptor degeneration has not yet occurred. As controls, some rats received injections of cell culture medium alone, or were not injected. Tests for visual function were performed at 60 and 90 days after birth, times at which loss of photoreceptor cells has produced characteristic vision deficits. As more fully described in the paper, test results of relative visual acuity demonstrated that animals receiving hES-derived RPE cells performed significantly better than cell culture medium treated or untreated controls. Treated animals showed a 50 percent improvement over medium-treated controls and a 100 percent improvement over untreated controls in visual performance. Visual acuity was approximately 70 percent of normal rats.

"One important advantage offered by hES-derived cells over other cells developed to mimic or replace lost retinal pigment epithelium is that they more closely resemble primary human RPEs," stated Raymond D. Lund, Ph.D., Professor at the Moran Eye Center, University of Utah Health Science Center, Salt Lake City and the study's lead author. "Another significant advantage of using these cells is that a range of lines can be derived allowing the opportunity to 'tissue match' donor cells with recipient, a real advantage given that RPE cells are highly immunogenic and susceptible to rejection without some form of immunosuppression."

"Embryonic stem cells promise to provide a well-characterized and reproducible source of replacement cells for clinical studies," stated Robert Lanza, M.D., Vice President of Research & Scientific Development at ACTC and senior author of the paper. "All 18 human embryonic stem cell lines we studied reliably produced retinal cells that could potentially be used to treat retinal degenerative diseases, such as macular degeneration. We showed that these cells have the capacity to rescue visual function in animals that otherwise would have gone blind. Importantly, the cells did not appear to cause any unwanted pathological responses in the animals following transplantation."

"We are working to generate clinical grade RPE cells from human embryonic stem cells under controlled GMP conditions," said Irina Klimanskaya, Ph.D., Director of Stem Cell Biology at ACTC, and the author who initiated this work. "However, more research is still required to optimize their performance and to assure they are safe for clinical trials."

"We are encouraged by this data related to our retinal program and are focused on driving therapies to the clinic," stated William M. Caldwell IV, CEO of ACTC.

Other authors include Shaomei Wang, Toby Holmes, Bin Lu, N. Bischoff, and Sergej Girman of the Moran Eye Center; Rebeca Ramos-Kelsey of Advanced Cell Technology, and Yves Sauve of the Ophthalmology and Physiology Dept., University of Alberta, Edmonton.

About Advanced Cell Technology, Inc.

Advanced Cell Technology Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com..

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

SOURCE: Advanced Cell Technology, Inc.


Media:
FD, Healthcare and Life Sciences
Robert Stanislaro, 212-850-5657
or
Investors:
The Investor Relations Group
James Carbonara, 212-825-3210
Copyright Business Wire 2006

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
I just picked up 10k. I watched ACOR go from $2-$11 in two days. This will do the same.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
God that would be GREAT!!!!!!!! [Big Grin]

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
Share count is about the same. When they get appropriations for the government this will be at $10. That would make it a $260m company.
Look at:
ASTM-$142m Company
STEM-$168m company

Now look at ACTC-$19m Company. This could go to $10 VERY easy.

Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
Im in! And thats why. [Smile]

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
Also, I see your from San Diego, I need your Padres to beat the Cardinals tonight, and tomorrow so the Astros win there division. Can you handle that for me?
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
DONE!

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
Sweet!!!!
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
Daddy Warbucks
Member


Member Rated:
5
Icon 1 posted      Profile for Daddy Warbucks     Send New Private Message       Edit/Delete Post   Reply With Quote 
Any word on when the Feds might pony up?

--------------------
Euthanasia? I'm American! Why should I care about kids over there??

Posts: 42 | From: in a van, DOWN BY THE RIVER!!! | Registered: Aug 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
None yet, but the most right winged conservatives are up for the idea if it doesn't damage the embryo. This will be up 500%+ first day when it does.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
Related Quotes
Sym. Price Chg.
ACTC Trade
News 0.69 0.05
Investor`s Business Daily Cites Advanced Cell Technology`s Scientific Leadership in Burgeoning Embryonic Stem Cell Industry

October 06, 2006 06:30:16 (ET)


ALAMEDA, Calif., Oct 06, 2006 (BUSINESS WIRE) -- Advanced Cell Technology, Inc. (ACTC, Trade), applying proprietary human embryonic stem (ES) cell technology to the emerging field of regenerative medicine, today announced that the Company was prominently featured by the newspaper "Investor's Business Daily" in an in-depth article highlighting top investment opportunities in the embryonic stem cell industry.

The Investor's Business Daily (IBD) article, titled "Patience an Asset in Stem Cell Work," details the current political and ethical debates limiting federal funding for stem cell research and development. The IBD newspaper suggests that Advanced Cell Technology's (ACTC) groundbreaking science and research may help speed the development of stem cell-based cures by addressing some of these scientific and ethical debates.

ACTC recently announced that Company scientists demonstrated the ability to generate new human embryonic stem cell lines by adapting a proven technique used at in vitro fertilization labs to determine genetic health. The ACTC approach maintains the embryo's potential for life, addressing one of the key debates in stem cell research by showing it is possible to generate embryonic stem cell lines without harming embryos.

ACTC has said its non-destructive technique may help open up the federal funding and speed the development of needed stem cell-based science and breakthrough therapies, according to the IBD article.

To accelerate its development programs, the article noted that ACTC recently moved to California where "voters approved a 10-year, $3 billion stem cell research fund in 2004."

"If you're going to survive you must be close to the capital," the article quoted William Caldwell IV, Chief Executive Officer of Advanced Cell Technology.

To read the entire article, please visit http://www.investors.com/editorial/IBDArticles.asp?artsec=22&issue=200 60929&view=1 (Due to its length, this URL may need to be copied/pasted into your Internet browser's address field. Remove the extra space if one exists.)

About Advanced Cell Technology, Inc.

Advanced Cell Technology Inc. is a biotechnology company applying embryonic stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information, please visit: www.advancedcell.com. For investor-specific information and resources, visit http://www.trilogy-capital.com/tcp/advanced_cell. To read or download Advanced Cell's Investor Fact Sheet, please visit http://www.trilogy-capital.com/tcp/advanced_cell/factsheet.html. To view recent stock quotes and news, visit http://www.trilogy-capital.com/tcp/advanced_cell/quote.html.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended March 31, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

SOURCE: Advanced Cell Technology, Inc.


Financial Dynamics
Robert Stanislaro, 212-850-5657 (Media)
or
The Investor Relations Group
James Carbonara, 212-825-3210 (Investors)
or
Financial Communications
Trilogy Capital Partners
Paul Karon, 800-592-6067
paul*trilogy-capital.com
Copyright Business Wire 2006

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
HossTrader
Member


Member Rated:
4
Icon 1 posted      Profile for HossTrader     Send New Private Message       Edit/Delete Post   Reply With Quote 
This is one of those companies in pinky land that kill me. This one is obviously legit. Tons of external verification. The magazine "Nature", IBD, etc. But at the same time being a bio-tech startup it will need tons of capital until it does hit.

The fact that I know it is legit makes me much more comfortable with the long run odds though.

--------------------
I just want to make enough money to be eccentric.

Posts: 2412 | From: Atlanta | Registered: Aug 2005  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
I picked up another 5000. This one will move like ACOR very soon.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
Jo4321
Member


Icon 1 posted      Profile for Jo4321     Send New Private Message       Edit/Delete Post   Reply With Quote 
Of course it will...now that I sold it yesterday for a 69% loss.

I'm not gonna watch....I'm not gonna watch (peeking)

Jo

--------------------
"Great Day for Up!"....Dr. Seuss

Posts: 3387 | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
[Smile]
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
HOSS, You in this one?

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
Do you know this has a P/E of 2. I guess there making money? That’s amazing. Not only will this be a $10 stock as soon as the government steps in, but they are already making money. Impressive.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
Repoman75
Member


Rate Member
Icon 1 posted      Profile for Repoman75         Edit/Delete Post   Reply With Quote 
It's at .65 now.. when it hits .40, I'll buy

--------------------
Stick with Repo's plan in '07 - FRPT/DKAM!

Posts: 6379 | From: PA | Registered: Dec 2004  |  IP: Logged | Report this post to a Moderator
HossTrader
Member


Member Rated:
4
Icon 1 posted      Profile for HossTrader     Send New Private Message       Edit/Delete Post   Reply With Quote 
quote:
Originally posted by IMAKEMONEY:
HOSS, You in this one?

I am in it just a little bit. I have maybe $1200 in it right now. This one looks to be at least a legit company, we are just betting on if they can hit the big score.

--------------------
I just want to make enough money to be eccentric.

Posts: 2412 | From: Atlanta | Registered: Aug 2005  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
quote:
Originally posted by Repoman75:
It's at .65 now.. when it hits .40, I'll buy

.40? Good luck with that. LoL.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
Just picked up another 5k. 20k total.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
J_U_ICE
Member


Member Rated:
4
Icon 1 posted      Profile for J_U_ICE     Send New Private Message       Edit/Delete Post   Reply With Quote 
Advanced Cell Technology's Dr. Robert Lanza Will Be a Featured Speaker at the 6th Annual Stem Cells & Regenerative Medicine Meeting
10/13/2006

ALAMEDA, Calif., Oct 13, 2006 (BUSINESS WIRE) --
Advanced Cell Technology, Inc.'s (OTCBB:ACTC) Robert Lanza, M.D., Vice President of Research & Scientific Development, will speak on "Human ESC-Derived Cells for Rescue of Visual Function and Repair of Vascular Damage," at the 6th Annual Stem Cells & Regenerative Medicine meeting October 16-17, 2006 at the Renaissance Pittsburgh Hotel in Pittsburgh, PA. Dr. Lanza will present on Monday, October 16th at 9:30 a.m. and such presentation shall be available on the company's website.

Embryonic stem cells promise to provide a well-characterized and reproducible source of replacement tissue for human clinical studies. Two early potential applications of this technology are the use of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) for the treatment of retinal degenerative diseases such as macular degeneration and retinitis pigmentosa, and the use of hESC-derived hemangioblasts for vascular restoration of organs and limbs. Recent progress using these cells to affect substantial functional and morphological rescue in animals will be discussed.

About Advanced Cell Technology, Inc.

Advanced Cell Technology, Inc. is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company operates facilities in Alameda, California and Worcester, Massachusetts. For more information about the company, please visit http://www.advancedcell.com.

Forward-Looking Statements

Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2006.

Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.

SOURCE: Advanced Cell Technology, Inc.

The Investor Relations Group Investor Relations: James Carbonara Media Relations: Bill Douglass 212-825-3210 or Financial Communications: Trilogy Capital Partners Paul Karon, 800-592-6067 paul*trilogy-capital.com

Copyright Business Wire 2006

--------------------
The difference between genius and stupidity is that genius has its limits

Posts: 10204 | From: NYC | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
Should RUN!!!!!!!!!!! [Big Grin]

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
ARCA IS FLIPPING!!

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
HossTrader
Member


Member Rated:
4
Icon 1 posted      Profile for HossTrader     Send New Private Message       Edit/Delete Post   Reply With Quote 
picked some more up at .715. This could get interesting

--------------------
I just want to make enough money to be eccentric.

Posts: 2412 | From: Atlanta | Registered: Aug 2005  |  IP: Logged | Report this post to a Moderator
HossTrader
Member


Member Rated:
4
Icon 1 posted      Profile for HossTrader     Send New Private Message       Edit/Delete Post   Reply With Quote 
In case anyone was wondering about that last pr

Conference web page

--------------------
I just want to make enough money to be eccentric.

Posts: 2412 | From: Atlanta | Registered: Aug 2005  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
This should get a response from the conference. The potential of this company, and the share price just don’t add up. The market cap at $10 is only $280m. This is a 10-15 billion dollar industry by 2010, and they have a patent on the leading technology. It doesn't damage the embryo. There should be no governmental dispute. I literally could see this at $20-$30 after appropriations.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
All right HOSS, Hope your right invester. IM IN!!

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
HossTrader
Member


Member Rated:
4
Icon 1 posted      Profile for HossTrader     Send New Private Message       Edit/Delete Post   Reply With Quote 
This is the type of pink I love to find. I can find NOTHING that makes me question that this company is actually trying to do what they say they are doing. They are conducting real research into products for a real market. It isn't just a share printing op, or another company pretending to jump on a hot topic.

That being said, there are no guarantees this company will be successful, or they won't have to raise more capital.

But at least with this one, you are gambling on them developing the technology and bringing it to market instead of gambling on wether or not the ceo is full of ****.

--------------------
I just want to make enough money to be eccentric.

Posts: 2412 | From: Atlanta | Registered: Aug 2005  |  IP: Logged | Report this post to a Moderator
IMAKEMONEY
Member


Icon 1 posted      Profile for IMAKEMONEY     Send New Private Message       Edit/Delete Post   Reply With Quote 
LOL HOSS, YEP.

--------------------
LIFE IS 10% HOW YOU MAKE IT AND 90% HOW YOU TAKE IT!

Posts: 9276 | From: San Diego CA | Registered: Jul 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
I would be buying all I can at this level.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
invester
Member


Icon 1 posted      Profile for invester     Send New Private Message       Edit/Delete Post   Reply With Quote 
Major buying coming in.
Posts: 4381 | From: houston | Registered: Mar 2006  |  IP: Logged | Report this post to a Moderator
  This topic comprises 3 pages: 1  2  3   

Quick Reply
Message:

HTML is enabled.
UBB Code™ is enabled.

Instant Graemlins
   


Post New Topic  Post A Reply Close Topic   Feature Topic   Move Topic   Delete Topic next oldest topic   next newest topic
 - Printer-friendly view of this topic
Hop To:


Contact Us | Allstocks.com Message Board Home

© 1997 - 2021 Allstocks.com. All rights reserved.

Powered by Infopop Corporation
UBB.classic™ 6.7.2

Share